Jääskeläinen, M.M.; Tumelius, R.; Hämäläinen, K.; Rilla, K.; Oikari, S.; Rönkä, A.; Selander, T.; Mannermaa, A.; Tiainen, S.; Auvinen, P.
High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer. Cancers 2024, 16, 634.
https://doi.org/10.3390/cancers16030634
AMA Style
Jääskeläinen MM, Tumelius R, Hämäläinen K, Rilla K, Oikari S, Rönkä A, Selander T, Mannermaa A, Tiainen S, Auvinen P.
High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer. Cancers. 2024; 16(3):634.
https://doi.org/10.3390/cancers16030634
Chicago/Turabian Style
Jääskeläinen, Minna M., Ritva Tumelius, Kirsi Hämäläinen, Kirsi Rilla, Sanna Oikari, Aino Rönkä, Tuomas Selander, Arto Mannermaa, Satu Tiainen, and Päivi Auvinen.
2024. "High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer" Cancers 16, no. 3: 634.
https://doi.org/10.3390/cancers16030634
APA Style
Jääskeläinen, M. M., Tumelius, R., Hämäläinen, K., Rilla, K., Oikari, S., Rönkä, A., Selander, T., Mannermaa, A., Tiainen, S., & Auvinen, P.
(2024). High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer. Cancers, 16(3), 634.
https://doi.org/10.3390/cancers16030634